Orchard Therapeutics Q3 EPS $(0.38) Beats $(0.43) Estimate, Sales $1.918M Beat $400K Estimate

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.43) by 11.63 percent. The company reported quarterly sales of $1.918 million which beat

Benzinga · 11/06/2019 21:30

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.43) by 11.63 percent. The company reported quarterly sales of $1.918 million which beat the analyst consensus estimate of $400 thousand by 379.50 percent.